Hu Li
Impact in
- Hepatology top 10%
- Hepatitis C virus research
- Liver Disease and Transplantation
-
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Epidemiology 16
- Liver Disease Diagnosis and Treatment 12
- Hepatitis B Virus Studies 5
- Hepatology 11
- Hepatitis C virus research 11
- Liver Disease and Transplantation 2
- Co-authors
- Zong‐Gen Peng (21 shared papers)Jian‐Dong Jiang (10 shared papers)Menghao Huang (6 shared papers)Jianrui Li (17 shared papers)Biao Dong (12 shared papers)Xuekai Wang (6 shared papers)Jian‐Dong Jiang (5 shared papers)Lei Lei (7 shared papers)
- Journals
- Frontiers in Pharmacology (3 papers)European Journal of Pharmacology (3 papers)Acta Pharmaceutica Sinica B (2 papers)Biomedicine & Pharmacotherapy (2 papers)Gut Microbes (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Hu Li
27 papers receiving 477 citations
Hu Li's Hit Papers
Peers
Comparison fields: 5 of 87
- Hepatology 101
- Epidemiology 157
- Pharmacology 35
- Immunology and Allergy 15
- Molecular Biology 179
Countries citing papers authored by Hu Li
This map shows the geographic impact of Hu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hu Li more than expected).
Fields of papers citing papers by Hu Li
This network shows the impact of papers produced by Hu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hu Li. The network helps show where Hu Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Hu Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bacteroides thetaiotaomicron ameliorates mouse hepatic steatosis through regulating gut microbial composition, gut-liver folate and unsaturated fatty acids metabolism Hit paper breakdown → | 2024 | 75 |
| 2 | 2018 | 71 | |
| 3 | 2006 | 66 | |
| 4 | 2016 | 48 | |
| 5 | 2018 | 29 | |
| 6 | 2022 | 25 | |
| 7 | 2018 | 21 | |
| 8 | 2019 | 20 | |
| 9 | 2022 | 19 | |
| 10 | 2022 | 14 | |
| 11 | 2020 | 13 | |
| 12 | 2020 | 11 | |
| 13 | 2024 | 11 | |
| 14 | 2019 | 11 | |
| 15 | 2020 | 8 | |
| 16 | 2001 | 7 | |
| 17 | 2022 | 6 | |
| 18 | 2019 | 6 | |
| 19 | 2017 | 5 | |
| 20 | 2021 | 5 |
About Hu Li
Hu Li is a scholar working on Epidemiology, Hepatology, Molecular Biology, Pharmacology and Oncology, having authored 29 papers that have together received 490 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (12 papers), Hepatitis C virus research (11 papers), Hepatitis B Virus Studies (5 papers), Drug Transport and Resistance Mechanisms (2 papers), Hormonal Regulation and Hypertension (2 papers), HER2/EGFR in Cancer Research (2 papers), Berberine and alkaloids research (2 papers) and Liver Disease and Transplantation (2 papers). The work is most often cited by research in Hepatology (101 citations), Epidemiology (157 citations), Pharmacology (35 citations), Immunology and Allergy (15 citations) and Molecular Biology (179 citations). Hu Li has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Zong‐Gen Peng, Jian‐Dong Jiang, Menghao Huang, Jianrui Li, Biao Dong, Xuekai Wang, Jian‐Dong Jiang, Lei Lei, Mei Tang and Jing Jiang. Their work appears in journals such as Frontiers in Pharmacology, European Journal of Pharmacology, Acta Pharmaceutica Sinica B, Biomedicine & Pharmacotherapy and Gut Microbes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.